Switch to
More onapp

How to use scorecard? Learn more

Panacea Biotec Ltd

PANACEABIO
Health CareBiotechnology
SmallcapWith a market cap of ₹838 cr, stock is ranked 1,453
High RiskStock is 4.86x as volatile as Nifty
137.850.90 (+0.66%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CareBiotechnology
SmallcapWith a market cap of ₹838 cr, stock is ranked 1,453
High RiskStock is 4.86x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
-68.81
PB RatioPB Ratio
1.00
Dividend YieldDiv. Yield
Sector PESector PE
43.83
Sector PBSector PB
5.97
Sector Div YldSctr Div Yld
0.59%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Panacea Biotec Limited is a health management company. The Company's principal business activity is the manufacture of allopathic pharmaceuticals preparations.

Financial TrendFinancial statements 

20202021202220230.570.632.350.61-0.19-0.151.08-0.03
Revenue
Profit
Loss
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Shareholders meeting 
Announced OnApr 13, 2024

Panacea Biotec Limited has submitted the Exchange a copy Srutinizers report alongwith voting results regarding Postal Ballot dated 13.02.2024. | Download

Panacea Biotec Limited has submitted the Exchange a copy Srutinizers report alongwith voting results regarding Postal Ballot dated 13.02.2024. | Download

Cessation 
Announced OnApr 1, 2024

Panacea Biotec Limited has informed the Exchange regarding Cessation of Mr Namdeo Narayan Khamitkar as Non- Executive Independent Director of the company w.e.f. March 31, 2024. | Download

Panacea Biotec Limited has informed the Exchange regarding Cessation of Mr Namdeo Narayan Khamitkar as Non- Executive Independent Director of the company w.e.f. March 31, 2024. | Download

Cash Dividend 
Ex. DateSep 19, 2011

Final • Div/Share: ₹ 0.75

See all events